A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
Active, not recruiting · NCT07122193 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States | Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Cholinergic Agents; Membrane Transport Modulators; Molecular Mechanisms of Pharmacological Action; Neuromuscular Agents; Neurotransmitter Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; incobotulinumtoxinA | Active, not recruiting | Phase 3 | 2026-09-10 | NCT07122193 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merz North America, Inc. | 6 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||